Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levo Phencynonate Hydrochloridefor the Prevention of Motion Sickness (Seasickness): a Randomized, Double-blind, Placebo Controlled, Multicenter,PhaseⅡClinical Study

NCT02241629 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.

NCT NCT02241629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02241629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levo Phencynonate Hydrochloridefor the Prevention of Motion Sickness (Seasickness): a Randomized, Double-blind, Placebo Controlled, Multicenter,PhaseⅡClinical Study
Lead sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2014
Completion date
February 28, 2015
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

motion sickness